BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

304 related articles for article (PubMed ID: 17007822)

  • 1. Biphasic cytoarchitecture and functional changes in the BBB induced by chronic inflammatory pain.
    Brooks TA; Ocheltree SM; Seelbach MJ; Charles RA; Nametz N; Egleton RD; Davis TP
    Brain Res; 2006 Nov; 1120(1):172-82. PubMed ID: 17007822
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Chronic inflammatory pain leads to increased blood-brain barrier permeability and tight junction protein alterations.
    Brooks TA; Hawkins BT; Huber JD; Egleton RD; Davis TP
    Am J Physiol Heart Circ Physiol; 2005 Aug; 289(2):H738-43. PubMed ID: 15792985
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Nociceptive inhibition prevents inflammatory pain induced changes in the blood-brain barrier.
    Campos CR; Ocheltree SM; Hom S; Egleton RD; Davis TP
    Brain Res; 2008 Jul; 1221():6-13. PubMed ID: 18554577
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inflammatory pain alters blood-brain barrier permeability and tight junctional protein expression.
    Huber JD; Witt KA; Hom S; Egleton RD; Mark KS; Davis TP
    Am J Physiol Heart Circ Physiol; 2001 Mar; 280(3):H1241-8. PubMed ID: 11179069
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Specific role of tight junction proteins claudin-5, occludin, and ZO-1 of the blood-brain barrier in a focal cerebral ischemic insult.
    Jiao H; Wang Z; Liu Y; Wang P; Xue Y
    J Mol Neurosci; 2011 Jun; 44(2):130-9. PubMed ID: 21318404
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Increased blood-brain barrier permeability and altered tight junctions in experimental diabetes in the rat: contribution of hyperglycaemia and matrix metalloproteinases.
    Hawkins BT; Lundeen TF; Norwood KM; Brooks HL; Egleton RD
    Diabetologia; 2007 Jan; 50(1):202-11. PubMed ID: 17143608
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [The tight junction proteins ZO-1, occludin and actin participate in the permeability increasing of blood-brain barrier induced by hypoxia-ischemia].
    Wu LW; Yin F; Peng J; Wang WD; Gan N
    Zhongguo Dang Dai Er Ke Za Zhi; 2008 Aug; 10(4):513-6. PubMed ID: 18706176
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Blood-brain barrier tight junctions are altered during a 72-h exposure to lambda-carrageenan-induced inflammatory pain.
    Huber JD; Hau VS; Borg L; Campos CR; Egleton RD; Davis TP
    Am J Physiol Heart Circ Physiol; 2002 Oct; 283(4):H1531-7. PubMed ID: 12234806
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of hypoxia-reoxygenation on rat blood-brain barrier permeability and tight junctional protein expression.
    Witt KA; Mark KS; Hom S; Davis TP
    Am J Physiol Heart Circ Physiol; 2003 Dec; 285(6):H2820-31. PubMed ID: 12907427
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Transforming growth factor-beta signaling alters substrate permeability and tight junction protein expression at the blood-brain barrier during inflammatory pain.
    Ronaldson PT; Demarco KM; Sanchez-Covarrubias L; Solinsky CM; Davis TP
    J Cereb Blood Flow Metab; 2009 Jun; 29(6):1084-98. PubMed ID: 19319146
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Astrocyte mediated modulation of blood-brain barrier permeability does not correlate with a loss of tight junction proteins from the cellular contacts.
    Hamm S; Dehouck B; Kraus J; Wolburg-Buchholz K; Wolburg H; Risau W; Cecchelli R; Engelhardt B; Dehouck MP
    Cell Tissue Res; 2004 Feb; 315(2):157-66. PubMed ID: 14615934
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ethanol-induced activation of myosin light chain kinase leads to dysfunction of tight junctions and blood-brain barrier compromise.
    Haorah J; Heilman D; Knipe B; Chrastil J; Leibhart J; Ghorpade A; Miller DW; Persidsky Y
    Alcohol Clin Exp Res; 2005 Jun; 29(6):999-1009. PubMed ID: 15976526
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Neutrophil transmigration in inflammatory bowel disease is associated with differential expression of epithelial intercellular junction proteins.
    Kucharzik T; Walsh SV; Chen J; Parkos CA; Nusrat A
    Am J Pathol; 2001 Dec; 159(6):2001-9. PubMed ID: 11733350
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Age and 17β-estradiol effects on blood-brain barrier tight junction and estrogen receptor proteins in ovariectomized rats.
    Sandoval KE; Witt KA
    Microvasc Res; 2011 Mar; 81(2):198-205. PubMed ID: 21192956
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Endophilin-1 regulates blood-brain barrier permeability by controlling ZO-1 and occludin expression via the EGFR-ERK1/2 pathway.
    Liu W; Wang P; Shang C; Chen L; Cai H; Ma J; Yao Y; Shang X; Xue Y
    Brain Res; 2014 Jul; 1573():17-26. PubMed ID: 24854121
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The role of hypoxia-inducible factor-1α, aquaporin-4, and matrix metalloproteinase-9 in blood-brain barrier disruption and brain edema after traumatic brain injury.
    Higashida T; Kreipke CW; Rafols JA; Peng C; Schafer S; Schafer P; Ding JY; Dornbos D; Li X; Guthikonda M; Rossi NF; Ding Y
    J Neurosurg; 2011 Jan; 114(1):92-101. PubMed ID: 20617879
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Decreased junctional adhesion molecule-A expression during blood-brain barrier breakdown.
    Yeung D; Manias JL; Stewart DJ; Nag S
    Acta Neuropathol; 2008 Jun; 115(6):635-42. PubMed ID: 18357461
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Increased caveolin-1 expression precedes decreased expression of occludin and claudin-5 during blood-brain barrier breakdown.
    Nag S; Venugopalan R; Stewart DJ
    Acta Neuropathol; 2007 Nov; 114(5):459-69. PubMed ID: 17687559
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Oxidative stress increases blood-brain barrier permeability and induces alterations in occludin during hypoxia-reoxygenation.
    Lochhead JJ; McCaffrey G; Quigley CE; Finch J; DeMarco KM; Nametz N; Davis TP
    J Cereb Blood Flow Metab; 2010 Sep; 30(9):1625-36. PubMed ID: 20234382
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Blood-brain barrier disruption and enhanced vascular permeability in the multiple sclerosis model EAE.
    Bennett J; Basivireddy J; Kollar A; Biron KE; Reickmann P; Jefferies WA; McQuaid S
    J Neuroimmunol; 2010 Dec; 229(1-2):180-91. PubMed ID: 20832870
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.